|Articles|May 26, 2016
Cenduit Announces Upgraded Patient Reminders Tool
Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, announced the release of its upgraded Patient Reminders tool.
Advertisement
Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, announced the release of its upgraded Patient Reminders tool. The upgraded features of this tool include a two-way messaging dashboard and a mobile app compatible with iPhone and Android devices.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
2
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
3
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
4
Using Global Patient Data to Design Smarter, More Inclusive Clinical Trials
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
